source
- GSK to cut 650 jobs as it shuts German vaccine plant and consolidates production in CanadaGSK announced it will close its vaccine manufacturing facility in Dresden, Germany, resulting in about 650 layoffs. The decision follows a review and aligns with a $2.5 billion cost‑saving program…
- GSK signs new agreement with China's Chimagen for trispecific T-cell engager targeting blood cancersGSK, the UK‑based pharmaceutical company, has entered into a fresh licensing agreement with Chinese biotech Chimagen Biosciences. The partnership focuses on a trispecific T‑cell engager designed fo…